CRA provided expert reports and testimony in several cases involving improper diversion of diabetes test strips. CRA’s damages analyses quantified the difference in profits earned on legitimate sales of test strips in the U.S. retail market as compared to profits earned on the diverted test strips (for example, those sold in international markets or those intended for other patient groups in the U.S.
12 CRA consultants named top IP professionals in the 2022 IAM Patent 1000
12 CRA consultants were recognized as leading patent professionals by Intellectual Asset Management (IAM). The IAM Patent 1000: The World’s Leading Patent...